Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Aquestive Therapeutics
Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA
News Wire ~ 3rd Party Press Release
-
2022/03/18
AQST-109 is the first orally delivered epinephrine-based product candidate for the emergency treatment of allergic reactions including anaphylaxis.
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
Dave Bloom
-
2022/03/02
The market for epinephrine delivery may expand to include non-needle alternatives next year.
Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration
Dave Bloom
-
2022/03/01
Company presented top level Phase 1 results at #AAAAI2022 meeting.
Sublingual Emergency Epinephrine Takes Another Step Forward in Phase 1 Study
Dave Bloom
-
2021/10/26
Aquestive's postage-stamp-sized film is designed to dissolve under the tongue to provide epinephrine.
Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine
Dave Bloom
-
2021/03/26
Company updates the public on status of their candidate drug administered under the tongue.
Emergency Epinephrine Film Begins Phase 1 Clinical Trials
Dave Bloom
-
2020/08/20
First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Aquestive’s Sublingual Epinephrine Film Receives FDA Fast Track Designation for Treatment...
News Wire ~ 3rd Party Press Release
-
2020/08/11
First planned PK clinical trial expected to begin during the third quarter of 2020.
Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine
News Wire ~ 3rd Party Press Release
-
2020/06/29
Epinephrine you slip under your tongue takes another step forward as the company submits their IND application.
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
News Wire ~ 3rd Party Press Release
-
2020/02/06
Emergency epinephrine candidate dissolves in the mouth.
Update on Delivery of Emergency Epinephrine via Sublingual Film
Dave Bloom
-
2019/03/14
Aquestive is finalizing the clinical trial application for a 2019Q2 study.
1
2
Page 2 of 2